• (5Z)-7-Oxozeaenol: Mapping TAK1 Causality

  2026-09-10

  Discover how (5Z)-7-Oxozeaenol functions as a selective TAK1 inhibitor for separating inflammatory signaling from AMPK–SQSTM1 metabolic adaptation. This article translates recent lysosomal stress findings into a causal, assay-centered workflow for interpreting NF-κB, JNK/p38 MAPK, COX-2, AMPK, and NRF2 readouts.

• USP42, JNK/p38, and Breast Cancer Apoptosis

  2026-09-10

  A 2025 Scientific Reports study identifies USP42 as a pro-tumorigenic factor in breast cancer and connects its depletion to activation of JNK/p38 signaling and apoptosis. The work combines expression analysis, loss-of-function experiments, pathway inhibition, and xenograft testing, providing a mechanistic framework while leaving direct USP42 substrates and clinical applicability for further study.

• NamiRNA–LNP Therapy in Pancreatic Cancer

  2026-09-09

  Yu et al. show that miR-200c suppresses pancreatic cancer through two distinct regulatory routes: enhancer-dependent activation of PTPN6 transcription and post-transcriptional repression of CDH17. LNP-based delivery extended this mechanism into an in vivo therapeutic framework, while also illustrating how proliferation and migration should be measured as related but separable phenotypes.

• Cardamomin and Oxidative Protection in Ischemic Stroke

  2026-09-09

  The reference study identifies cardamomin from Amomum villosum Lour. as a preclinical protector against hydrogen peroxide-induced oxidative injury and permanent cerebral ischemia. Its main contribution is a connected mechanism involving MEK/ERK-dependent NRF2 activation, suppression of oxeiptosis, and limitation of AIFM1-associated parthanatos, supported by complementary cellular and rat experiments.

• SB743921 Workflows for Mitotic Arrest Studies

  2026-09-08

  Build more informative KSP-inhibition assays by separating mitotic growth arrest from irreversible cell death. This workflow uses SB743921 for mechanism-focused profiling, concentration optimization, and translational comparison across cancer cell lines and tumor xenograft models.

• Birinapant (TL32711): From IAP Biology to Translation

  2026-09-08

  Birinapant (TL32711) offers a mechanistically focused way to test how IAP-dependent survival signaling shapes apoptosis and treatment response. By connecting its SMAC mimetic activity with evidence linking MDM1, p53, and apoptosis to chemoradiotherapy sensitivity, this article presents a biomarker-led framework for translational cancer research.

• Leucovorin Calcium in Cancer Assays

  2026-09-07

  Leucovorin Calcium enables controlled methotrexate-rescue experiments in organoids, assembloids, and cell proliferation assays. This workflow uses calcium folinate to distinguish epithelial folate dependence from stromal modulation while improving interpretation of antifolate drug resistance research.

• Protoporphyrin IX in Ferroptosis Workflows

  2026-09-07

  Protoporphyrin IX enables paired dark–light experiments that separate photodynamic stress from iron- and lipid-dependent cell death. This practical guide connects heme formation, photodynamic cancer diagnosis, and the METTL16–SENP3–LTF ferroptosis axis while emphasizing formulation, controls, and interpretation limits.

• Abiraterone Acetate in 3D Prostate Models

  2026-09-05

  Use Abiraterone acetate as a controlled CYP17 inhibitor challenge in patient-derived prostate spheroids, while separating target biology from solubility and exposure effects. This workflow combines three-dimensional viability, androgen receptor activity inhibition, biomarker profiling, and practical troubleshooting for more defensible prostate cancer research.

• Isradipine (Dynacirc) in Calcium Channel Studies

  2026-09-04

  Isradipine (Dynacirc) provides a practical way to probe L-type calcium influx across neuronal, vascular, and cardiac research models. This guide connects stock preparation and assay design with concentration-aware controls, helping distinguish genuine channel modulation from vehicle, cell-state, and selectivity artifacts.

• Reactive Oxygen Species Assay Kit for FLASH-RT

  2026-09-04

  Discover how the Reactive Oxygen Species Assay Kit and DCFH-DA fluorescent probe can clarify redox responses during FLASH radiotherapy research. This guide connects live-cell ROS measurement with BRD4-targeted radiosensitization, experimental controls, and interpretation limits.

• ATS-9R for Targeted Adipose Gene Silencing

  2026-09-03

  ATS-9R enables non-viral delivery of shRNA or sgRNA/Cas9 complexes to white adipose tissue and adipose tissue macrophages. This practical guide covers complex formation, tissue-selective assay design, TACE-focused workflows, optimization, and troubleshooting for obesity-associated inflammation research.

• Patient-Derived Gastric Cancer Assembloids

  2026-09-03

  The reference study introduces patient-derived gastric cancer assembloids that combine matched tumor organoids with tumor-derived stromal subpopulations, improving representation of cellular heterogeneity and tumor–stroma interactions. Its drug-response and transcriptomic results show why stromal context can alter biomarker expression, progression-associated programs, and therapeutic sensitivity.

• Poly-PR, HSP70, and TDP-43 Condensates

  2026-09-02

  Agnihotri et al. show that C9ORF72-associated poly-PR promotes NEAT1-dependent TDP-43 nuclear condensates and that HSP70 helps preserve their fluidity during transient stress. With prolonged poly-PR exposure, HSP70 delocalization is associated with TDP-43 oligomerization, condensate hardening, mislocalization, and increased cellular toxicity, providing a mechanistic framework for ALS and FTD research.

• PD98059 MEK Inhibitor: Workflow and Applications

  2026-09-02

  PD98059 provides a reversible way to test how MEK–ERK1/2 signaling controls leukemic differentiation, proliferation, and apoptosis. This practical guide covers stock preparation, time-resolved pathway assays, neuroprotection research, and troubleshooting for reproducible MAPK experiments.

8681 records 1/579 page Next 12345 下5页 Last page